Skip to content

Robotic Knee Orthosis-assisted Walking in CP

A Pilot Study to Examine the Effect of a Powered Knee Orthosis on Crouch Gait in Cerebral Palsy

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06887764
Enrollment
10
Registered
2025-03-20
Start date
2025-02-10
Completion date
2026-04-25
Last updated
2026-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebral Palsy (CP), Crouch Gait

Keywords

Robotic Knee Orthosis, Crouch Gait, Flexed-knee Gait, Cerebral Palsy

Brief summary

Robotic exoskeletons are becoming increasingly accepted to provide upright mobility in individuals with neurological disorders. These devices can assist in overcoming gravitational forces and reduce energy consumption. Agilik is one such device intended for individuals with neurological disorders. However, Agilik is relatively new, and its efficacy in individuals with CP is unknown. Therefore, this study aims to assess the effectiveness of Agilik as an assistive device for individuals with CP and crouch gait. In this pilot study, ten individuals with CP, GMFCS levels I and II, and crouch gait will walk with Agilik under the supervision of a physical therapist. Assessments of walking with shoes or AFO and Agilik will evaluate the efficacy of the device. The pilot study will assess if Agilik decreases crouch and improves gait characteristics in individuals with CP.

Detailed description

Robotic knee orthosis (RKO) can assist with voluntary knee extension and potentially reduce crouch/flexed-knee gait, but the effectiveness of this technology in individuals with CP is unknown. This study aims to assess the efficacy of Agilik as an assistive device for individuals with CP. Ten individuals with CP, ages 8 to 65 years, and at GMFCS levels I and II, will be recruited for this pilot study. Each individual will participate in a maximum of four sessions/ visits. The first three sessions will include RKO device fitting and tuning, followed by RKO-assisted walking practice to help with device acclimation. These sessions will last up to 60 minutes. A two-minute walk test (2MWT) will also be conducted at the first visit, which will serve as a reference to assess any shift in endurance from device-tuning/ practice. The final visit will include 2MWT and 3D motion capture in shod (shoes or shoes+AFO) and RKO-assisted (shoes+RKO or shoes+AFO+RKO) conditions, and may take up to 3 to 4 hours.

Interventions

DEVICERKO-assisted walking in individuals with CP

The investigators will assess walking in each of the following conditions: shod (shoes or shoes+AFO) and RKO-assisted (shoes+RKO or shoes+AFO+RKO), to achieve the following: (1) Evaluate the effect of RKO, compared to shod upon endurance in individuals with CP at GMFCS levels I and II, and (2) Evaluate the effect of RKO, compared to shod, upon temporal-spatial parameters, lower limb sagittal joint kinematics, and muscle EMG in individuals with CP at GMFCS levels I and II.

Sponsors

Hospital for Special Surgery, New York
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
8 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Diagnosed with cerebral palsy at GMFCS levels I and II * Exhibits crouch gait * Between 8 to 65 years of age * Hip flexion contracture less than 10 degrees * Knee flexion contracture less than 20 degrees when measured in prone with hips extended * Thigh-foot angle is between 15 degrees (internal) to 30 degrees (external) in prone * Can walk a minimum distance of 10 meters without stopping

Exclusion criteria

* No other neurological, musculoskeletal, or cardiorespiratory health conditions or injuries * The presence of any cognitive impairment that could limit the ability to understand, follow simple directions, and inform when in pain * Inability to participate in the study because of recent orthopedic surgery (within twelve months)

Design outcomes

Primary

MeasureTime frameDescription
Distance from 2MWTFrom enrollment until data collection is performed on the fourth study session.The distance covered by participants during a two-minute walking test (2MWT) will be compared between RKO-assisted and shod conditions.
Step lengthAt the end of the study visit for each participant, data collection will be performed during the fourth study session from enrollment.Mean step length (distance between the two feet measured from the heel of one foot to the heel of the contralateral foot while both feet are on the ground) during walking will be compared between RKO-assisted and shod conditions.
Single limb support timeAt the end of the study visit for each participant, data collection will be performed during the fourth study session from enrollment.Mean single limb support time (duration just one foot by itself is on the ground) during walking will be compared between RKO-assisted and shod conditions.
Walking speedAt the end of the study visit for each participant, data collection will be performed during the fourth study session from enrollment.Mean walking speed during walking will be compared between RKO-assisted and shod conditions.
Lower limb joint kinematicsAt the end of the study visit for each participant, data collection will be performed during the fourth study session from enrollment.The sagittal plane lower limb joint angles (degrees) during walking will be compared to evaluate the difference between RKO-assisted and shod conditions.
Binary indicator of improvement in walking distance with RKO useAt the end of the study visit for each participant, data collection will be performed during the fourth study session from enrollment."Yes" if the walking distance in the RKO-assisted condition was greater than shod, and "No" if there was no improvement.
Lower limb electromyography dataAt the end of the study visit for each participant, data collection will be performed during the fourth study session from enrollment.Electromyography (EMG) amplitude and duration of lower limb anti-gravity muscles (rectus femoris, vastus lateralis, vastus medialis, medial gastrocnemius, soleus, and gluteus maximus) will be compared between RKO-assisted and shod conditions. The EMG data will be filtered and rectified to compute linear envelopes. From these envelopes, the average value of EMG amplitude and duration will be compared between RKO-assisted and shod conditions.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 19, 2026